Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates
Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, today announced financial results for the full year ended December 31, 2017. The Company also summarized recent program updates and reiterated full-year 2018 revenue and net cash spend guidance. As quoted in the press release: John F. …
Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, today announced financial results for the full year ended December 31, 2017. The Company also summarized recent program updates and reiterated full-year 2018 revenue and net cash spend guidance.
As quoted in the press release:
John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics, Inc. stated, “Throughout 2017 we continued to build a leading global rare disease biotech company. In the early part of 2018 we have made significant progress to further advance our vision to maximize the impact of our medicines for people living with rare metabolic diseases. There is tremendous momentum for the launch and regulatory review processes for Galafold as we expand global access to this important oral precision medicine for Fabry disease. In addition, the longer term data from our Pompe clinical study further strengthen the potential of our new treatment paradigm for this devastating muscle disease. With these key value drivers in Fabry and Pompe, supported by a strengthened balance sheet and several pipeline opportunities, Amicus is well positioned to create significant near- and long-term value for patients and shareholders.”
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1816.77 | -1.80 | |
Silver | 20.67 | -0.15 | |
Copper | 3.77 | -0.01 | |
Palladium | 1970.88 | +101.88 | |
Platinum | 916.88 | +6.88 | |
Oil | 111.84 | +0.08 | |
Heating Oil | 4.04 | -0.08 | |
Natural Gas | 6.56 | -0.01 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â